AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Tannenbaum, GS Bowers, CY
Citation: Gs. Tannenbaum et Cy. Bowers, Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin, ENDOCRINE, 14(1), 2001, pp. 21-27

Authors: Veldhuis, JD Evans, WS Bowers, CY Anderson, S
Citation: Jd. Veldhuis et al., Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2, ENDOCRINE, 14(1), 2001, pp. 45-62

Authors: Bowers, CY Granda-Ayala, R
Citation: Cy. Bowers et R. Granda-ayala, Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH(2) and in combination in older men and women with decreased growth hormonesecretion, ENDOCRINE, 14(1), 2001, pp. 79-86

Authors: Bowers, CY Schally, AV Hawley, WD Gual, C Parlow, A
Citation: Cy. Bowers et al., Effect of thyrotropin-releasing factor in man, ENDOCRINOLO, 11(5), 2001, pp. 352-356

Authors: Dimaraki, EV Jaffe, CA Demott-Friberg, R Russell-Aulet, M Bowers, CY Marbach, P Barkan, AL
Citation: Ev. Dimaraki et al., Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator, AM J P-ENDO, 280(3), 2001, pp. E489-E495

Authors: Gondo, RG Aguiar-Oliveira, MH Hayashida, CY Toledo, SPA Abelin, N Levine, MA Bowers, CY Souza, AHO Pereira, RMC Santos, NL Salvatori, R
Citation: Rg. Gondo et al., Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficientpatients with mutated GH-releasing hormone receptor, J CLIN END, 86(7), 2001, pp. 3279-3283

Authors: Bowers, CY
Citation: Cy. Bowers, Unnatural growth hormone-releasing peptide begets natural ghrelin, J CLIN END, 86(4), 2001, pp. 1464-1469

Authors: Anderson, SM Shah, N Evans, WS Patrie, JT Bowers, CY Veldhuis, JD
Citation: Sm. Anderson et al., Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women, J CLIN END, 86(2), 2001, pp. 551-560

Authors: Evans, WS Anderson, SM Hull, LT Azimi, PP Bowers, CY Veldhuis, JD
Citation: Ws. Evans et al., Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states, J CLIN END, 86(2), 2001, pp. 700-712

Authors: Wideman, L Weltman, JY Patrie, JT Bowers, CY Shah, N Story, S Weltman, A Veldhuis, JD
Citation: L. Wideman et al., Synergy of L-arginine and growth hormone (GH)-releasing peptide-2 on GH release: influence of gender, AM J P-REG, 279(4), 2000, pp. R1455-R1466

Authors: Wideman, L Weltman, JY Patrie, JT Bowers, CY Shah, N Story, S Veldhuis, JD Weltman, A
Citation: L. Wideman et al., Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise, AM J P-REG, 279(4), 2000, pp. R1467-R1477

Authors: Maas, HCM de Vries, WR Maitimu, I Bol, E Bowers, CY Koppeschaar, HPF
Citation: Hcm. Maas et al., Growth hormone responses during strenuous exercise: the role of GH-releasing hormone and GH-releasing peptide-2, MED SCI SPT, 32(7), 2000, pp. 1226-1232

Authors: Shah, N Evans, WS Bowers, CY Veldhuis, JD
Citation: N. Shah et al., Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women, J CLIN END, 85(8), 2000, pp. 2649-2659

Authors: Van den Berghe, G Baxter, RC Weekers, F Wouters, P Bowers, CY Veldhuis, JD
Citation: G. Van Den Berghe et al., A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness, J CLIN END, 85(1), 2000, pp. 183-192

Authors: Bowers, CY
Citation: Cy. Bowers, GHRP historical perspective - Basic and clinical, CONT ENDOC, 19, 2000, pp. 17-43

Authors: Van den Berghe, G Wouters, P Bowers, CY de Zegher, F Bouillon, R Veldhuis, JD
Citation: G. Van Den Berghe et al., Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness (vol 140, pg 17, 1999), EUR J ENDOC, 140(3), 1999, pp. 268-268

Authors: Van den Berghe, G Wouters, P Bowers, CY de Zegher, F Bouillon, R Veldhuis, JD
Citation: G. Van Den Berghe et al., Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness, EUR J ENDOC, 140(1), 1999, pp. 17-22

Authors: Meacham, LR Culler, FL Abdul-Latif, H Sullivan, KM Bowers, CY
Citation: Lr. Meacham et al., Preservation of growth hormone secretion in response to growth hormone-releasing peptide-2 during prednisone therapy, METABOLISM, 48(5), 1999, pp. 585-589

Authors: Shah, N Evans, WS Bowers, CY Veldhuis, JD
Citation: N. Shah et al., Tripartite neuroendocrine activation of the human growth hormone (GH) axisin women by continuous 24-hour GH-releasing peptide infusion: Pulsatile, entropic, and nyctohemeral mechanisms, J CLIN END, 84(6), 1999, pp. 2140-2150

Authors: Van den Berghe, G Wouters, P Weekers, F Mohan, S Baxter, RC Veldhuis, JD Bowers, CY Bouillon, R
Citation: G. Van Den Berghe et al., Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormonein patients with protracted critical illness, J CLIN END, 84(4), 1999, pp. 1311-1323

Authors: Bowers, CY
Citation: Cy. Bowers, Growth hormone-releasing peptide (GHRP), CELL MOL L, 54(12), 1998, pp. 1316-1329
Risultati: 1-21 |